211 related articles for article (PubMed ID: 27839916)
21. Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson's Disease.
Monfrini E; Di Fonzo A
Adv Neurobiol; 2017; 14():3-30. PubMed ID: 28353276
[TBL] [Abstract][Full Text] [Related]
22. Correlation between LRRK2 gene G2385R polymorphisms and Parkinson's disease.
Yan H; Ma Q; Yang X; Wang Y; Yao Y; Li H
Mol Med Rep; 2012 Oct; 6(4):879-83. PubMed ID: 22842796
[TBL] [Abstract][Full Text] [Related]
23. Increased basal forebrain volumes could prevent cognitive decline in LRRK2 Parkinson's disease.
Batzu L; Urso D; Grothe MJ; Veréb D; Chaudhuri KR; Pereira JB
Neurobiol Dis; 2023 Jul; 183():106182. PubMed ID: 37286171
[TBL] [Abstract][Full Text] [Related]
24. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.
Ross OA; Soto-Ortolaza AI; Heckman MG; Aasly JO; Abahuni N; Annesi G; Bacon JA; Bardien S; Bozi M; Brice A; Brighina L; Van Broeckhoven C; Carr J; Chartier-Harlin MC; Dardiotis E; Dickson DW; Diehl NN; Elbaz A; Ferrarese C; Ferraris A; Fiske B; Gibson JM; Gibson R; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lesage S; Lin CH; Lynch T; Maraganore DM; Mellick GD; Mutez E; Nilsson C; Opala G; Park SS; Puschmann A; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Theuns J; Tomiyama H; Uitti RJ; Valente EM; van de Loo S; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Farrer MJ;
Lancet Neurol; 2011 Oct; 10(10):898-908. PubMed ID: 21885347
[TBL] [Abstract][Full Text] [Related]
25. Peripheral synucleinopathy in Parkinson disease with LRRK2 G2385R variants.
Yang J; Wang H; Yuan Y; Fan S; Li L; Jiang C; Mao C; Shi C; Xu Y
Ann Clin Transl Neurol; 2021 Mar; 8(3):592-602. PubMed ID: 33527742
[TBL] [Abstract][Full Text] [Related]
26. Heart rate variability in leucine-rich repeat kinase 2-associated Parkinson's disease.
Visanji NP; Bhudhikanok GS; Mestre TA; Ghate T; Udupa K; AlDakheel A; Connolly BS; Gasca-Salas C; Kern DS; Jain J; Slow EJ; Faust-Socher A; Kim S; Azhu Valappil R; Kausar F; Rogaeva E; William Langston J; Tanner CM; Schüle B; Lang AE; Goldman SM; Marras C
Mov Disord; 2017 Apr; 32(4):610-614. PubMed ID: 28071824
[TBL] [Abstract][Full Text] [Related]
27. Quantitative assessment of the effect of LRRK2 exonic variants on the risk of Parkinson's disease: a meta-analysis.
Wu X; Tang KF; Li Y; Xiong YY; Shen L; Wei ZY; Zhou KJ; Niu JM; Han X; Yang L; Feng GY; He L; Qin SY
Parkinsonism Relat Disord; 2012 Jul; 18(6):722-30. PubMed ID: 22575234
[TBL] [Abstract][Full Text] [Related]
28. LRRK2 G2385R and R1628P mutations are associated with an increased risk of Parkinson's disease in the Malaysian population.
Gopalai AA; Lim SY; Chua JY; Tey S; Lim TT; Mohamed Ibrahim N; Tan AH; Eow GB; Abdul Aziz Z; Puvanarajah SD; Viswanathan S; Looi I; Lim SK; Tan LP; Chong YB; Tan CT; Zhao Y; Tan EK; Ahmad-Annuar A
Biomed Res Int; 2014; 2014():867321. PubMed ID: 25243190
[TBL] [Abstract][Full Text] [Related]
29. The Parkinson's disease-associated mutation LRRK2 G2385R alters mitochondrial biogenesis via the PGC-1α-TFAM pathway.
Xue J; Zhang J; Zhang J; Liu J; Wang F; Li K; Liu C
Mitochondrion; 2023 Nov; 73():10-18. PubMed ID: 37708949
[TBL] [Abstract][Full Text] [Related]
30. Serum Uric Acid in LRRK2 Related Parkinson's Disease: Longitudinal Data from the PPMI Study.
Bougea A; Koros C; Papagiannakis N; Simitsi AM; Prentakis A; Papadimitriou D; Pachi I; Antonelou R; Angelopoulou E; Beratis I; Bozi M; Papageorgiou SG; Trapali XG; Stamelou M; Stefanis L
J Parkinsons Dis; 2021; 11(2):633-640. PubMed ID: 33682725
[TBL] [Abstract][Full Text] [Related]
31. Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls.
Agalliu I; Ortega RA; Luciano MS; Mirelman A; Pont-Sunyer C; Brockmann K; Vilas D; Tolosa E; Berg D; Warø B; Glickman A; Raymond D; Inzelberg R; Ruiz-Martinez J; Mondragon E; Friedman E; Hassin-Baer S; Alcalay RN; Mejia-Santana H; Aasly J; Foroud T; Marder K; Giladi N; Bressman S; Saunders-Pullman R
Mov Disord; 2019 Sep; 34(9):1392-1398. PubMed ID: 31348549
[TBL] [Abstract][Full Text] [Related]
32. Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson's disease.
Carricarte Naranjo C; Marras C; Visanji NP; Cornforth DJ; Sanchez-Rodriguez L; Schüle B; Goldman SM; Estévez M; Stein PK; Lang AE; Jelinek HF; Machado A
Clin Auton Res; 2019 Dec; 29(6):603-614. PubMed ID: 31444591
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the role of LRRK2 gene in Parkinson's disease in an East Indian cohort.
Sadhukhan T; Vishal M; Das G; Sharma A; Mukhopadhyay A; Das SK; Ray K; Ray J
Dis Markers; 2012; 32(6):355-62. PubMed ID: 22684232
[TBL] [Abstract][Full Text] [Related]
34. LRRK2 G2019S Parkinson's disease with more benign phenotype than idiopathic.
Ben Romdhan S; Farhat N; Nasri A; Lesage S; Hdiji O; Ben Djebara M; Landoulsi Z; Stevanin G; Brice A; Damak M; Gouider R; Mhiri C
Acta Neurol Scand; 2018 Nov; 138(5):425-431. PubMed ID: 29989150
[TBL] [Abstract][Full Text] [Related]
35. Genetic analysis of LRRK2 in Parkinson's disease in Han Chinese population.
Zhang JR; Jin H; Li K; Mao CJ; Yang YP; Wang F; Gu CC; Zhang HJ; Chen J; Liu CF
Neurobiol Aging; 2018 Dec; 72():187.e5-187.e10. PubMed ID: 30049590
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the LRRK2 Gly2385Arg variant in Alzheimer's disease in Taiwan.
Chang TY; Kuo HC; Lu CS; Wu-Chou YH; Huang CC
Parkinsonism Relat Disord; 2010 Jan; 16(1):28-30. PubMed ID: 19640773
[TBL] [Abstract][Full Text] [Related]
37. Effect of a Leucine-rich Repeat Kinase 2 Variant on Motor and Non-motor Symptoms in Chinese Parkinson's Disease Patients.
Sun Q; Wang T; Jiang TF; Huang P; Li DH; Wang Y; Xiao Q; Liu J; Chen SD
Aging Dis; 2016 May; 7(3):230-6. PubMed ID: 27330837
[TBL] [Abstract][Full Text] [Related]
38. Quantitative digital clock drawing test as a sensitive tool to detect subtle cognitive impairments in early stage Parkinson's disease.
Schejter-Margalit T; Kizony R; Shirvan J; Cedarbaum JM; Bregman N; Thaler A; Giladi N; Mirelman A
Parkinsonism Relat Disord; 2021 Sep; 90():84-89. PubMed ID: 34416663
[TBL] [Abstract][Full Text] [Related]
39. Penetrance of Parkinson disease LRRK2 G2385R-associated variant in the Chinese population.
Wang P; Cui P; Luo Q; Chen J; Tang H; Zhang L; Chen S; Ma J
Eur J Neurol; 2022 Sep; 29(9):2639-2644. PubMed ID: 35608967
[TBL] [Abstract][Full Text] [Related]
40. Clinical Features of LRRK2 Carriers with Parkinson's Disease.
Kestenbaum M; Alcalay RN
Adv Neurobiol; 2017; 14():31-48. PubMed ID: 28353277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
